Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 10

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

334

HTML

2337

Figures (1-4)

172

Tables (1-2)

171

Sum=3014

Mar 14, 2008 (publication date) through Nov 30, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Mar 14, 2008; 14(10): 1521-1527
Published online Mar 14, 2008. doi: 10.3748/wjg.14.1521

Table 2 Clinical and analytical data of Crohn disease’s patients

¹Number of GMA-apheresis sessions to achieve the healing: 13 for PG, 5 for E N.

Citation: Cuadrado E, Alonso M, Juan MD, Echaniz P, Arenas JI. Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis. World J Gastroenterol 2008; 14(10): 1521-1527
URL: https://www.wjgnet.com/1007-9327/full/v14/i10/1521.htm
DOI: https://dx.doi.org/10.3748/wjg.14.1521